You are here

Grants Awarded



Click on any project title for a more detailed description of the project. For more information about any of these awards (e.g., PI contact information or associated publications), please use the corresponding project number to search for information at the NIH Reporter website. Consistent with NIH policy, abstracts are not available for projects receiving their first award within the past year, so descriptions provided below are from the NCI program director.

New awards will be posted as they are issued.

Year Award Type Project # RFA # PI/Project Leader Institution Title Statussort ascending
2016 R21 CA202875 RFA-CA-15-002 LARMAN, HARRY BENJAMIN JOHNS HOPKINS UNIVERSITY A HIGHLY MULTIPLEXED GENE EXPRESSION PLATFORM FOR FIXED TISSUE SPECIMENS Complete
2000 R21 CA083241 PAR-99-100 MALKHOSYAN, SERGEI R BURNHAM INSTITUTE FOR MEDICAL RESEARCH COMPARATIVE HYBRIDIZATION OF AP PCR ARRAYS Complete
2002 R33 CA094360 PAR-01-104 SPEICHER, DAVID W. WISTAR INSTITUTE DEVELOPMENT OF METHODS FOR CANCER BIOMARKER DETECTION Complete
2005 R21 CA111994 RFA-CA-05-004 MAKRIGIORGOS, G. MIKE DANA-FARBER CANCER INSTITUTE GENOME AMPLIFICATION TOLERANT TO SAMPLE DEGRADATION Complete
2008 R21 CA125336 RFA-CA-07-035 NOLTE, DAVID D PURDUE UNIVERSITY WEST LAFAYETTE MULTIPLEXED ASSAYS ON THE BIOCD FOR ACUTE LYMPHOCYTIC LEUKEMIA Complete
2011 R21 CA157366 RFA-CA-10-005 LEVY, MATTHEW ALBERT EINSTEIN COLLEGE OF MEDICINE TARGETING CANCER CELLS WITH FUNCTIONALIZED NANOPARTICLE LIBRARIES Complete
2015 R21 CA196468 RFA-CA-14-005 KRUMMEL, MATTHEW F UNIVERSITY OF CALIFORNIA, SAN FRANCISCO LIVING TUMOR BIOPSIES TO INTERROGATE IMMUNE FUNCTION AND RESPONSE TO THERAPY Complete
2011 R21 CA128692 RFA-CA-10-005 CLARY, BRYAN M DUKE UNIVERSITY IN VIVO SELECTION OF TUMOR-SPECIFIC RNA BINDING MOTIFS Complete
2015 R33 CA182384 RFA-CA-14-004 BURKE, PETER J. UNIVERSITY OF CALIFORNIA-IRVINE HIGH-THROUGHPUT ON-CHIP PLATFORM FOR INTERROGATION OF MITOCHONDRIAL MEMBRANE POTENTIAL AND APOPTOSIS Complete
1999 R43 CA081962 PAR-98-066 GERDES, JOHN CHARLES XTRANA, INC. QUANTITATION AND ARCHIVING OF GENE EXPRESSION Complete
2001 R44 CA083396 PAR-99-101 GITE, SADANAND AMBERGEN, INC NOVEL TECHNOLOGY FOR THE ANALYSIS OF GENE EXPRESSION Complete
2004 R44 CA107988 PAR-01-105 BALGLEY, BRIAN M CALIBRANT BIOSYSTEMS, INC. INTEGRATED TOP-DOWN/BOTTOM-UP COMPREHENSIVE PROTEOMICS Complete
2007 R43 CA125605 RFA-CA-07-010 BOGEN, STEVEN A MEDICAL DISCOVERY PARTNERS, LLC ISOLATION OF CIRCULATING TUMOR CELLS FROM PERIPHERAL BLOOD Complete
2010 R33 CA143453 RFA-CA-09-007 BESTOR, TIMOTHY H COLUMBIA UNIVERSITY HEALTH SCIENCES MAMMARY CARCINOMA AND GENOMIC METHYLATION PATTERNS Complete
2014 R33 CA183654 RFA-CA-13-004 NOLAN, GARRY P. STANFORD UNIVERSITY HIGHLY MULTIPLEXED ION-BEAM TISSUE MOLECULAR IMAGING WITH SUB-MICRON RESOLUTION Complete
2017 R33 CA214333 RFA-CA-16-002 ZENG, YONG UNIVERSITY OF KANSAS LAWRENCE Integrated exosomes profiling for minimally invasive diagnosis and monitoring of cancer Complete
1999 R21 CA081732 PAR-98-067 STRAUSS, WILLIAM M BETH ISRAEL DEACONESS MEDICAL CENTER EVALUATION OF SEQUENCE SPECIFIC CHANGES IN GENOMIC DNA Complete
2001 R33 CA089706 PAR-99-100 LAM, KIT S UNIVERSITY OF CALIFORNIA DAVIS PEPTIDE MICROARRAY FOR CANCER CELL SURFACE RECEPTORS Complete
2003 R43 CA103085 PAR-01-105 SCHNEIDER, LUKE V TARGET DISCOVERY IDBEST DIFFERENTIAL DISPLAY ON PROTEIN CHIPS Complete
2007 R21 CA125337 RFA-CA-07-002 KAUFMAN, DAVID G. UNIV OF NORTH CAROLINA CHAPEL HILL IDENTIFICATION OF AREAS OF OXIDATIVE DAMAGE IN HUMAN GENOMIC DNA Complete
2009 R44 CA140047 RFA-CA-08-011 CHEN, WEN-TIEN VITATEX, INC. CANCER PROGENIYOR CELL MARKERS Complete
2013 R33 CA174562 RFA-CA-12-005 TSENG, HSIAN-RONG UNIVERSITY OF CALIFORNIA LOS ANGELES MOLECULAR AND FUNCTIONAL ANALYSIS OF SINGLE CIRCULATING MELANOMA CELLS Complete
2000 R43 CA086178 PAR-99-101 WILLETT, CATHERINE E PHYLONIX PHARMACEUTICALS, INC. PHARMACOGENOMICS OF CARCINOGENESIS IN WHOLE ANIMALS Complete
2002 R43 CA096083 PAR-01-105 YANG, CHIHAE LEADSCOPE, INC. A NOVEL CHEMICAL GENOMICS METHODOLOGY Complete
2006 R21 CA123018 RFA-CA-06-003 SHI, HUIDONG UNIVERSITY OF MISSOURI-COLUMBIA EPIGENETIC TARGETING IN NON-HODGKIN'S LYMPHOMA Complete
2009 R21 CA137707 RFA-CA-08-006 GRZYBOWSKI, BARTOSZ ANDRZEJ NORTHWESTERN UNIVERSITY MICROASSAY SYSTEMS FOR DIAGNOSIS OF CANCER CELL MOTILITY AND METASTASIS Complete
2012 R33 CA160011 RFA-CA-12-003 NOLLING, JORK N PRIMERADX, INC. A HIGHLY MULTIPLEXED PCR PLATFORM FOR GENE EXPRESSION PROFILING FROM FFPE TISSUE Complete
2016 R21 CA202831 RFA-CA-15-002 LIANG, FU-SEN UNIVERSITY OF NEW MEXICO NOVEL BI-FUNCTIONAL INHIBITORS BLOCKING ONCOMIR BIOGENESIS Complete
2000 R21 CA088197 PAR-99-100 CHEE, MARK S. ILLUMINA, INC. PROTEIN PROFILING ARRAYS Complete
2002 R33 CA097513 PAR-01-106 SHAUGHNESSY, JOHN DAMIAN UNIVERSITY OF ARKANSAS MED SCIS LTL ROCK MOLECULAR DIAGNOSIS AND PROGNOSIS OF MULTIPLE MYELOMA Complete
2005 R21 CA114167 RFA-CA-05-004 LARSON, DALE N HARVARD UNIVERSITY (MEDICAL SCHOOL) DEVELOPMENT OF AN AUTOMATED FROZEN SAMPLE ALIQUOTTER Complete
2008 R21 CA126733 RFA-CA-07-037 WONG, DAVID T UNIVERSITY OF CALIFORNIA LOS ANGELES COLLECTION, STABILIZATION AND STORAGE OF SALIVA SAMPLES FOR CANCER RESEARCH Complete
2020 R21 CA247638 RFA-CA-19-019 LIANG, FU-SEN CASE WESTERN RESERVE UNIVERSITY Spatiotemporal Epitranscriptome Editing Technology Active
2019 R33 CA235302 RFA-CA-18-003 DE VLAMINCK, IWIJN CORNELL UNIVERSITY Spatially Resolved Metagenomics to Explore Tumor-Microbiome Interactions in Human Colorectal Cancer Active
2018 R33 CA217702 RFA-CA-17-013 BORGES, CHAD R ARIZONA STATE UNIVERSITY-TEMPE CAMPUS Validation and Advanced Development of Albumin Oxidizability as a Marker of Plasma/Serum Integrity Active
2020 R44 CA236097 PAR-18-303 LIM, MARK AMBERGEN, INC Highly Multiplexed Nanoscale Mass Spectrometric Imaging Of Cancer Tissues Active
2019 R33 CA235319 RFA-CA-18-003 YANG, JENNY J. GEORGIA STATE UNIVERSITY Multi-color Mapping of Cancer Molecular Signatures and Tumor microenvironment Active
2020 R43 CA250885 PAR-18-303 REDER, NICHOLAS LIGHTSPEED MICROSCOPY, INC. Open-top Light-sheet Microscopy For Non-destructive 3d Pathology Of Prostate Biopsies Active
2019 R33 CA235597 RFA-CA-18-003 SOPER, STEVEN ALLAN UNIVERSITY OF KANSAS LAWRENCE Increased Sensitivity of Minimal Residual Disease Monitoring using Peripheral Blood in Pediatric Patients with Acute Lymphoblastic Leukemia Active
2018 R43 CA236097 PAR-18-303 LIM, MARK AMBERGEN, INC Highly Multiplexed Nanoscale Mass Spectrometric Imaging of Cancer Tissues Active
2020 R21 CA251052 RFA-CA-19-019 SHVETS, GENNADY CORNELL UNIVERSITY Phenotypic Assay For Drug Discovery And Personalized Medicine Based On Real-time Vibrational Spectroscopy Enhanced By Plasmonic Metasurfaces Active
2019 R33 CA236687 RFA-CA-18-003 BREUNIG, JOSHUA JOHN CEDARS-SINAI MEDICAL CENTER GESTALT Barcoding and Single-cell Transcriptomics of Tumor Cell Evolution in Personalized Tumor Models Active
2020 R21 CA225493 RFA-CA-19-019 TEWARI, MUNEESH UNIVERSITY OF MICHIGAN AT ANN ARBOR Highly Specific, Amplification-free, Single-molecule Counting Of Rare Methylated Dna Cancer Biomarkers Active
2019 R33 CA240201 RFA-CA-18-003 VAN DAM, ROBERT MICHAEL UNIVERSITY OF CALIFORNIA LOS ANGELES Optimization and validation of integrated microscale technologies for low-cost; automated production of PET molecular imaging tracers for cancer research Active
2020 R33 CA251037 RFA-CA-19-020 WANG, SIYUAN YALE UNIVERSITY Multiplexed Imaging Of Chromatin Folding And Rna Profiles In Cancer Active
2019 R21 CA236652 RFA-CA-18-004 SINGAMANENI, SRIKANTH WASHINGTON UNIVERSITY METAL-ORGANIC FRAMEWORK AS PROTECTIVE COATING FOR CANCER BIOSPECIMEN PRESERVATION Active
2018 R21 CA229044 RFA-CA-17-010 ABBOTT, KAREN L UNIV OF ARKANSAS FOR MED SCIS Novel platform linking cancer-specific glycosylation with cell signaling outcomes Active
2020 R43 CA236167 PAR-18-303 WARREN, CHRISTOPHER L PROTEOVISTA, LLC Development Of The High Throughput Apt-snap Platform For Rapid Identification Ofnuclease-resistant Rna Aptamers Against P53 Missense Mutations Active
2019 R21 CA240219 RFA-CA-18-004 ANDRES-MARTIN, LAURA NEW YORK STEM CELL FOUNDATION Establishing efficient technologies for ovarian cancer organoid derivation from fresh tumor resections Active
2018 R21 CA223901 RFA-CA-17-010 BRENT, ROGER FRED HUTCHINSON CANCER RESEARCH CENTER Precision controllers of mammalian gene expression Active

Pages



National Cancer Institute at the National Institutes of Health

 

NIH… Turning Discovery Into Health®